Success Metrics

Clinical Success Rate
77.8%

Based on 7 completed trials

Completion Rate
78%(7/9)
Active Trials
2(11%)
Results Posted
29%(2 trials)
Terminated
2(11%)

Phase Distribution

Ph phase_3
2
11%
Ph phase_1
10
53%
Ph phase_2
3
16%

Phase Distribution

10

Early Stage

3

Mid Stage

2

Late Stage

Phase Distribution15 total trials
Phase 1Safety & dosage
10(66.7%)
Phase 2Efficacy & side effects
3(20.0%)
Phase 3Large-scale testing
2(13.3%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

77.8%

7 of 9 finished

Non-Completion Rate

22.2%

2 ended early

Currently Active

2

trials recruiting

Total Trials

19

all time

Status Distribution
Active(4)
Completed(7)
Terminated(2)
Other(6)

Detailed Status

Completed7
unknown6
Recruiting2
Enrolling by invitation2
Terminated2

Development Timeline

Analytics

Development Status

Total Trials
19
Active
2
Success Rate
77.8%
Most Advanced
Phase 3

Trials by Phase

Phase 110 (66.7%)
Phase 23 (20.0%)
Phase 32 (13.3%)

Trials by Status

unknown632%
recruiting211%
enrolling_by_invitation211%
completed737%
terminated211%

Recent Activity

Clinical Trials (19)

Showing 19 of 19 trials
NCT04804891Phase 1

Using T-Cell Alloreactivity and Chimerism to Guide Immunosuppression Minimization in Intestinal Transplantation

Recruiting
NCT06096038Phase 1

Autologous CAR-T Cells Targeting CSPG4 in Relapsed/Refractory HNSCC

Recruiting
NCT01325636Phase 1

Injection of CD4 and CD8 + T Cells Anti-Cytomegalovirus (CMV) or Anti-adenovirus

Completed
NCT06671275Phase 1

A Clinical Study to Evaluate CUD005 Injection in Patients with Liver Cirrhosis

Enrolling By Invitation
NCT06296095Phase 1

To Evaluate the Clinical Study of CUD005 Injection in Patients With Cirrhosis

Enrolling By Invitation
NCT02923609Phase 2

Cell Therapy in HFpEF

Completed
NCT03877471Phase 1

Mesenchymal Stem Cells (MSCs) - Like Cell Transplantation in Women With Primary Ovarian Insufficiency

Unknown
NCT01098591

Meta-Analysis of Cell-based CaRdiac stUdiEs: ACCRUE

Completed
NCT03040674

An Observational Outcomes Study for Autologous Cell Therapy Among Patients With COPD and Interstitial Lung Disease

Completed
NCT03797040Phase 1

Open-label Phase I Study for PEP or Treatment of HS-ARS PLX-R18 for the Post-Exposure Prevention (PEP) or Treatment of Hematopoietic Syndrome of Acute Radiation Syndrome (HS-ARS)

Unknown
NCT01727063Phase 3

Cell Therapy in Severe Chronic Ischemic Heart Disease

Completed
NCT03044431

Autologous Stem Cell Treatment for Chronic Lung Disease Study

Completed
NCT01557543Phase 1

Stem Cell Injection to Treat Heart Damage During Open Heart Surgery

Terminated
NCT01873547Phase 3

Different Efficacy Between Rehabilitation Therapy and Stem Cells Transplantation in Patients With SCI in China

Completed
NCT00130377Phase 2

Evaluation of the Treatment of Thoracic & Cardiovascular Disease With Biological Therapy: ClinicalCellRegistry.Com

Unknown
NCT01357785Phase 1

Periodontal Tissue Regeneration Using Autologous Periodontal Ligament Stem Cells

Unknown
NCT00377897Phase 1

Cell Therapy With Bone Marrow Mononuclear Cells in Critical Leg Ischemia (CLI)

Unknown
NCT00612911

Cell Therapy in Dilated Cardiomyopathy: Observational Study

Terminated
NCT00149006Phase 2

Cell Therapy of Cancer With Allogeneic Blood Lymphocytes Activated With Recombinant Interleukin-2 (rIL-2) for Metastatic Solid Tumors

Unknown

All 19 trials loaded

Drug Details

Intervention Type
BIOLOGICAL
Total Trials
19